Gene test may forecast sepsis survival
NCT ID NCT07533994
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explored whether measuring the activity of a gene called Acod1 in blood cells can help predict which sepsis patients are at higher risk of dying. Researchers enrolled 52 adults in the ICU and measured Acod1 levels within 48 hours of admission. The goal was to see if this gene could serve as a new tool for early risk assessment, alongside standard scores like SOFA and APACHE II.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Critical Care Medicine, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan
Wuhan, Hubei, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?